Results 201 to 210 of about 16,692 (213)

Human Serum Paraoxonase 1 Decreases Macrophage Cholesterol Biosynthesis

Arteriosclerosis, Thrombosis, and Vascular Biology, 2003
Diana M Shih, Michael Aviram
exaly  

Paraoxonase PON1 Polymorphism Leu-Met54 Is Associated With Carotid Atherosclerosis : Results of the Austrian Stroke Prevention Study

Stroke, 1998
Helena Schmidt, Reinhold Schmidt, Kurt Niederkorn   +2 more
exaly  

Preservation of Paraoxonase Activity by Wine Flavonoids

Annals of the New York Academy of Sciences, 2002
Bianca Fuhrman, Michael Aviram
exaly  

Paraoxonases

2013
openaire   +1 more source

Paraoxonase 1 (PON1) inhibits monocyte-to-macrophage differentiation

Atherosclerosis, 2011
Nina Volkova, Mira Rosenblat, Michael Aviram   +2 more
exaly  

The antioxidant HDL-associated paraoxonase-1 (PON1) attenuates diabetes development and stimulates β-cell insulin release

Atherosclerosis, 2011
Tony Hayek, Michael Aviram
exaly  

Some indazoles reduced the activity of human serum paraoxonase 1, an antioxidant enzyme: in vitro inhibition and molecular modeling studies

Archives of Physiology and Biochemistry, 2019
Zuhal Alim, Deryanur Kilic, Yeliz Demir
exaly  

Paraoxonase Active Site Required for Protection Against LDL Oxidation Involves Its Free Sulfhydryl Group and Is Different From That Required for Its Arylesterase/Paraoxonase Activities : Selective Action of Human Paraoxonase Allozymes Q and R

Arteriosclerosis, Thrombosis, and Vascular Biology, 1998
Robert Newton, Mira Rosenblat, M Aviram
exaly  

Paraoxonase

1997
HUDSON PETER L, HE WEI W, RUBEN STEVEN M
openaire   +1 more source

[Arylesterase, paraoxonase].

Nihon rinsho. Japanese journal of clinical medicine, 2005
Yukio, Ikeda, Tadashi, Suehiro
openaire   +1 more source